北大青鳥環宇(08095.HK)擬向鎵特半導體科技(上海)增資1億元
格隆匯7月7日丨北大青鳥環宇(08095.HK)發佈公吿,於2022年7月7日,公司、現有股東及目標公司鎵特半導體科技(上海)有限公司訂立增資協議,據此,公司同意向目標公司增資人民幣1億元。
目標公司為一間於中國註冊成立的公司。其主要從事(i)半導體和新材料技術的技術開發、技術服務、技術諮詢和技術轉讓;(ii)半導體材料和設備的銷售;(iii)貨物和技術的進出口(凡依法須經批准的業務,經相關部門批准後方可開展)。
於公司完成增資後,公司將持有目標公司約22.86%股權。
董事認為,增資實屬投資良機,並符合集團的願景,即投資於具有可觀前景的目標公司或業務。增資讓集團得以加大其對目標公司及其業務活動的投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.